Compare NUAI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUAI | OSUR |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | NUAI | OSUR |
|---|---|---|
| Price | $2.79 | $2.44 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 6.0M | 666.2K |
| Earning Date | 02-14-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $843,029.00 | ★ $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.89 | N/A |
| 52 Week Low | $0.32 | $2.08 |
| 52 Week High | $7.87 | $4.22 |
| Indicator | NUAI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 47.54 |
| Support Level | $2.88 | $2.41 |
| Resistance Level | $4.97 | $2.46 |
| Average True Range (ATR) | 0.58 | 0.10 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 5.20 | 28.81 |
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.